Triple-negative breast cancer is highly invasive and has poor prognosis. Defining triple-negative breast cancer only based on immunohistochemistry is not comprehensive, it is necessary to classify triplenegative breast cancer from molecular stratification, which is useful for guiding the therapy clinically. This article is to sum up the existing clinical classification methods of triple-negative breast cancer, and review on related targeted therapy methods.
| 
推荐 
点击下列相关研究机构和相关文献作者，可以直接查到这些机构和作者被《中国知识资源总库》收录的其它文献，使您全面了解该机构和该作者的研究动态和历史。
